TranscriptionMolecular BiologyPeer-reviewed journal article
RNA polymerases from Low G+C Gram Positive Bacteria
Abstract
The low G+C Gram positive bacteria represent some of the most medically and industrially important microorganisms. They are relied on for the production of food and dietary supplements, enzymes and antibiotics, as well as being responsible for the majority of nosocomial infections and serving as a reservoir for antibiotic resistance. Control of gene expression in this group is more highly studied than in any bacteria other than the Gram negative model Escherichia coli, yet until recently no structural information on RNA polymerase (RNAP) from this group was available. This review will summarise recent reports on the high resolution structure of RNAP from the model low G+C representative Bacillus subtilis, including the role of auxiliary subunits {delta} and {varepsilon}, and outline approaches for the development of antimicrobials to target RNAP from this group.
- Citations
- 6
- FWCI
- 0.15
- Field percentile
- 16th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antibacterial nucleoside-analog inhibitor of bacterial RNA polymerase: pseudouridimycin
Sonia Ilaria Maffioli, Yu Zhang, … Richard H. Ebright·CellPeer-reviewed·Jun 1, 2017
- 6S RNA-dependent antibiotic susceptibility
M. Esberard, M. Hallier, … P. Bouloc·bioRxiv·Jan 31, 2022
- A decrease in transcription capacity limits growth rate upon translation inhibition
Q. Zhang, E. Brambilla, … B. Sclavi·bioRxiv·Oct 9, 2019
- Structural basis for the unexpected activity of rifamycin B against rifampicin-resistant RNA polymerase
Hamed Mosaei, Yeonoh Shin, … Nikolay Zenkin·bioRxiv·Jul 14, 2026
- Structural basis and mechanism of action of NrdR, a bacterial master regulator of ribonucleotide reduction
Lucas Pedraz, Arkadiusz Szura, … Eduard Torrents·bioRxiv·Mar 28, 2025
- Mutations in rpoB that confer rifampicin resistance can alter levels of peptidoglycan precursors and affect β-lactam susceptibility
Y. Patel, V. Soni, … J. D. Helmann·bioRxiv·Nov 14, 2022